As of close of business last night, Exact Sciences Corp.’s stock clocked out at $62.00, down -1.05% from its previous closing price of $62.66. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 3974006 shares were traded. EXAS stock price reached its highest trading level at $65.22 during the session, while it also had its lowest trading level at $61.87.
Ratios:
To gain a deeper understanding of EXAS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 352.49. For the most recent quarter (mrq), Quick Ratio is recorded 2.07 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.79.
On December 14, 2023, Guggenheim started tracking the stock assigning a Buy rating and target price of $90.
On December 13, 2023, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.Wolfe Research initiated its Outperform rating on December 13, 2023, with a $95 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 01 ’24 when Conroy Kevin T sold 8,271 shares for $59.32 per share. The transaction valued at 490,636 led to the insider holds 1,299,496 shares of the business.
LEVANGIE DANIEL J sold 5,000 shares of EXAS for $287,500 on Mar 01 ’24. The Director now owns 22,975 shares after completing the transaction at $57.50 per share. On Mar 01 ’24, another insider, Cunningham Everett, who serves as the Chief Commercial Officer of the company, sold 2,412 shares for $59.32 each. As a result, the insider received 143,080 and left with 46,179 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 11.25B and an Enterprise Value of 13.03B. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.50 while its Price-to-Book (P/B) ratio in mrq is 3.58. Its current Enterprise Value per Revenue stands at 5.21 whereas that against EBITDA is 445.04.
Stock Price History:
Over the past 52 weeks, EXAS has reached a high of $100.77, while it has fallen to a 52-week low of $56.05. The 50-Day Moving Average of the stock is 62.06, while the 200-Day Moving Average is calculated to be 73.32.
Shares Statistics:
It appears that EXAS traded 1.92M shares on average per day over the past three months and 2.08M shares per day over the past ten days. A total of 181.36M shares are outstanding, with a floating share count of 179.64M. Insiders hold about 1.04% of the company’s shares, while institutions hold 90.13% stake in the company. Shares short for EXAS as of Feb 29, 2024 were 7.04M with a Short Ratio of 3.67, compared to 7.29M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.88% and a Short% of Float of 3.91%.
